News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare Release: DaTSCAN™ (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact on the Diagnosis of Patients With Clinically Uncertain Dementia With Lewy Bodies


3/21/2013 10:32:28 AM

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare today presented the results of a randomized study analyzing the effect of DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with a diagnosis of possible dementia with Lewy bodies (DLB). The findings, presented at the 2013 American Academy of Neurology Meeting, reported use of DaTSCAN imaging significantly contributed to a change in diagnostic category and improved physician confidence in diagnosing these patients.1

Read at BioSpace.com


comments powered by Disqus
   
Dementia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES